Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

<p>Abstract</p> <p>Background</p> <p>Coinfection with hepatitis B virus (HBV) or hepatitis C virus (HCV) in HIV-infected patients receiving a commonly used nevirapine-based antiretroviral therapy is a major concern for African clinicians owing to its high prevalence, th...

Full description

Bibliographic Details
Main Authors:	Gwet Henri, Calmy Alexandra, Ciaffi Laura, Bourgeois Anke, Kouanfack Charles, Laurent Christian, Mbougua Jules, Koulla-Shiro Sinata, Ducos Jacques, Mpoudi-Ngolé Eitel, Molinari Nicolas, Delaporte Eric
Format:	Article
Language:	English
Published:	BMC 2010-03-01
Series:	BMC Public Health
Online Access:	http://www.biomedcentral.com/1471-2458/10/105

Similar Items

Antiretroviral Drug Resistance and Routine Therapy, Cameroon
by: Christian Laurent, et al.
Published: (2006-06-01)

HIV and Hepatitis C Virus Coinfection, Cameroon
by: Christian Laurent, et al.
Published: (2007-03-01)

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
by: Elvis Temfack, et al.
Published: (2018-03-01)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
by: Florian Liégeois, et al.
Published: (2020-01-01)

Commercial Logging and HIV Epidemic, Rural Equatorial Africa
by: Christian Laurent, et al.
Published: (2004-11-01)

Nevirapine plasma concentrations are associated with virologic response and hepatotoxicity in Chinese patients with HIV infection.
by: Jia Wang, et al.
Published: (2011-01-01)

Antioxidant modulation of nevirapine induced hepatotoxicity in rats
by: Awodele Olufunsho, et al.
Published: (2015-03-01)

Possible hepatotoxic consequence of nevirapine use in juvenile albino rats
by: Elias Adikwu, et al.
Published: (2017-08-01)

Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City
by: Rolf Nyah-tuku Nzalie, et al.
Published: (2016-01-01)

Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan
by: Yu-Tzu Tseng, et al.
Published: (2014-12-01)

Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.
by: Avelin F Aghokeng, et al.
Published: (2009-01-01)

Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013).
by: Jean Joel R Bigna, et al.
Published: (2015-01-01)

Combined antiretroviral therapy with nevirapine of HIV-infected adults
by: A V Kravchenko
Published: (2004-11-01)

Characterization of HIV-1 <it>gag</it> and <it>nef</it> in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
by: Tongo Marcel, et al.
Published: (2013-01-01)

Problématiques statistiques rencontrées dans l’étude du traitement antirétroviral des adultes infectés par le VIH en Afrique subsaharienne
by: Tchatchueng Mbougua, Jules Brice
Published: (2012)

Soil-transmitted helminth infections in free-ranging non-human primates from Cameroon and Gabon
by: C. Sirima, et al.
Published: (2021-07-01)

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.
by: Anitha Moorthy, et al.
Published: (2009-01-01)

Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
by: Erika Aaron, et al.
Published: (2010-01-01)

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
by: Gomez M Luisa, et al.
Published: (2008-10-01)

Exposure to Nonhuman Primates in Rural Cameroon
by: Nathan D. Wolfe, et al.
Published: (2004-12-01)

Epidemiology of Opportunistic Infections in HIV Infected Patients on Treatment in Accredited HIV Treatment Centers in Cameroon
by: Ornella Sybile D. Kouanfack, MD, et al.
Published: (2019-12-01)

Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
by: Ako A Agbor, et al.
Published: (2014-01-01)

Severe eye complications from toxic epidermal necrolysis following initiation of Nevirapine based HAART regimen in a child with HIV infection: a case from Cameroon
by: Xavier Tchetnya, et al.
Published: (2018-03-01)

Assessing the causes of under-five mortality and proportion associated with pneumococcal diseases in Cameroon. A case-finding retrospective observational study: 2006-2012.
by: John Njuma Libwea, et al.
Published: (2019-01-01)

Fatal Nevirapine-Induced Toxic Epidermal Necrolysis in a HIV Infected Patient
by: Sabyasachi Paik, et al.
Published: (2016-03-01)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
by: Phoorisri Thanongsri, et al.
Published: (2007-03-01)

Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon
by: Judith N. Torimiro, et al.
Published: (2013-04-01)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in CameroonResearch in context
by: Gaëlle F. Tchouwa, et al.
Published: (2018-07-01)

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.
by: Firmin Nongodo Kabore, et al.
Published: (2017-01-01)

Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa.
by: Kathryn M Chu, et al.
Published: (2010-02-01)

<it>HLA-Cw*04 </it>allele associated with nevirapine-induced rash in HIV-infected Thai patients
by: Tunthanathip Preecha, et al.
Published: (2009-10-01)

Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults
by: Fatai A. Fehintola, et al.
Published: (2012-01-01)

Incidence and determinants of nevirapine and efavirenz-related skin rashes in West Africans: nevirapine's epitaph?
by: Fred Stephen Sarfo, et al.
Published: (2014-01-01)

Seroprevalence of Toxoplasma gondii infection among pregnant women in Cameroon
by: Anna L. Njunda, et al.
Published: (2011-09-01)

A cross-sectional study of acute dengue infection in paediatric clinics in Cameroon
by: Salomon Bonsi Tchuandom, et al.
Published: (2019-07-01)

The Burden of Serious Fungal Infections in Cameroon
by: Christine E. Mandengue, et al.
Published: (2018-03-01)

Human Parvovirus 4 Infection, Cameroon
by: Myriam Lavoie, et al.
Published: (2012-04-01)

Comparison of nevirapine plasma concentrations between lead-in and steady-state periods in Chinese HIV-infected patients.
by: Huijuan Kou, et al.
Published: (2013-01-01)

Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy
by: C Padmapriyadarsini, et al.
Published: (2017-01-01)

Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.
by: Jayne Byakika-Tusiime, et al.
Published: (2008-01-01)

Cannot write session to /tmp/vufind_sessions/sess_2c5sqas5lr755v7a2c796pb2jv